BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9761127)

  • 1. Cytosol concentrations of CD44 isoforms in breast cancer tissue.
    Hefler L; Tempfer C; Haeusler G; Kucera E; Mayerhofer K; Zeillinger R; Reinthaller A; Kainz C
    Int J Cancer; 1998 Oct; 79(5):541-5. PubMed ID: 9761127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of immunohistochemically detected CD44 isoforms CD44v5, CD44v6 and CD44v7-8 in human breast cancer.
    Tempfer C; Lösch A; Heinzl H; Häusler G; Hanzal E; Kölbl H; Breitenecker G; Kainz C
    Eur J Cancer; 1996 Oct; 32A(11):2023-5. PubMed ID: 8943691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44 is an independent prognostic factor in early-stage cervical cancer.
    Speiser P; Wanner C; Tempfer C; Mittelböck M; Hanzal E; Bancher-Todesca D; Gitsch G; Reinthaller A; Kainz C
    Int J Cancer; 1997 Apr; 74(2):185-8. PubMed ID: 9133453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of CD44 isoform expression in endometrial cancer.
    Tempfer C; Haeusler G; Kaider A; Hefler L; Hanzal E; Reinthaller A; Breitenecker G; Kainz C
    Br J Cancer; 1998 Apr; 77(7):1137-9. PubMed ID: 9569051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble CD44 standard, CD44 variant 5 and CD44 variant 6 and their relation to staging in head and neck cancer.
    Kawano T; Yanoma S; Nakamura Y; Ozeki A; Kokatsu T; Kubota A; Furukawa M; Tsukuda M
    Acta Otolaryngol; 2005 Apr; 125(4):392-7. PubMed ID: 15823810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44 isoforms with exon v6 and metastasis of primary N0M0 breast carcinomas.
    Guriec N; Gairard B; Marcellin L; Wilk A; Caldéroli H; Renaud R; Bergerat JP; Oberling F
    Breast Cancer Res Treat; 1997 Jul; 44(3):261-8. PubMed ID: 9266106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The cytosolic hyaluronic acid level defines several clinico-biological properties of CD44v5-positive infiltrating ductal carcinoma of the breast].
    Ruibal A; Arias JI; Carmen del Río M; San Román JM; Lapeña G; Schneider J; Tejerina A
    Med Clin (Barc); 2000 Jul; 115(6):201-7. PubMed ID: 11002457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble CD44 splice variants and pelvic lymph node metastasis in ovarian cancer patients.
    Stickeler E; Vogl FD; Denkinger T; Mobus VJ; Kreienberg R; Runnebaum IB
    Int J Mol Med; 2000 Nov; 6(5):595-601. PubMed ID: 11029531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 splice variants as prognostic markers in colorectal cancer.
    Wielenga VJ; van der Voort R; Mulder JW; Kruyt PM; Weidema WF; Oosting J; Seldenrijk CA; van Krimpen C; Offerhaus GJ; Pals ST
    Scand J Gastroenterol; 1998 Jan; 33(1):82-7. PubMed ID: 9489913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44v6 is not a prognostic factor in primary breast cancer.
    Jansen RH; Joosten-Achjanie SR; Arends JW; Volovics A; Hupperets PS; Schouten HC; Hillen HF
    Ann Oncol; 1998 Jan; 9(1):109-11. PubMed ID: 9541692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44v6 expression in primary breast carcinoma in western India: a pilot clinicopathologic study.
    Shah NG; Trivedi TI; Vora HH; Patel KC; Tankshali R; Goswami JV; Shukla SN; Shah PM
    Tumori; 2010; 96(6):971-7. PubMed ID: 21388061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of soluble adhesion molecules CD44 (CD44st, CD44v5, CD44v6), ICAM-1, and VCAM-1 as tumor markers in head and neck cancer.
    Kawano T; Yanoma S; Nakamura Y; Shiono O; Kokatu T; Kubota A; Furukawa M; Tsukuda M
    Am J Otolaryngol; 2005; 26(5):308-13. PubMed ID: 16137528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of adhesion molecule CD44v6 in women with primary breast carcinoma: a clinicopathologic study.
    Ma W; Deng Y; Zhou L
    Clin Oncol (R Coll Radiol); 2005 Jun; 17(4):258-63. PubMed ID: 15997921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CD44 isoforms correlates with the metastatic potential of osteosarcoma.
    Kim HS; Park YB; Oh JH; Jeong J; Kim CJ; Lee SH
    Clin Orthop Relat Res; 2002 Mar; (396):184-90. PubMed ID: 11859242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD44v3 and v6 variant isoform expression correlates with poor prognosis in early-stage vulvar cancer.
    Tempfer C; Sliutz G; Haeusler G; Speiser P; Reinthaller A; Breitenecker G; Vavra N; Kainz C
    Br J Cancer; 1998 Oct; 78(8):1091-4. PubMed ID: 9792156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of the adhesion molecule CD44v6 in infiltrating ductal carcinomas of the breast is associated with hormone dependence. Our experience with 168 cases].
    Ruibal A; Schneider J; del Río MC; Arias J; Núñez MI; Tejerina A
    Rev Esp Med Nucl; 2000 Sep; 19(5):350-5. PubMed ID: 11062111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the CD44 variant isoforms 6 and 4/5 in breast cancer. Correlation with established prognostic parameters.
    Regidor PA; Callies R; Regidor M; Günthert U; Zöller M; Schindler AE
    Arch Gynecol Obstet; 1996; 258(3):125-35. PubMed ID: 8781700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased soluble CD44 concentrations are associated with larger tumor size and lymph node metastasis in breast cancer patients.
    Mayer S; zur Hausen A; Watermann DO; Stamm S; Jäger M; Gitsch G; Stickeler E
    J Cancer Res Clin Oncol; 2008 Nov; 134(11):1229-35. PubMed ID: 18438684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of CD44 and CD44v6 in colorectal carcinoma patients: soluble forms in relation to tumor tissue expression and metastasis.
    Amirghofran Z; Jalali SA; Hosseini SV; Vasei M; Sabayan B; Ghaderi A
    J Gastrointest Cancer; 2008; 39(1-4):73-8. PubMed ID: 19333790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical detection of adhesion molecule CD44 splice variants in lymph node metastases of cervical cancer.
    Kainz C; Tempfer C; Kohlberger P; Janisch S; Koelbl H; Gitsch G; Breitenecker G
    Int J Cancer; 1996 Jun; 69(3):170-3. PubMed ID: 8682582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.